SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around upcoming staking updates and airdrop details, creating excitement. The community buzzes about token burns, achieving new milestones, and the potential for future utilities. Brokecoin continues to gain traction within the Solana meme coin ecosystem, fueled by a dedicated community and ongoing development efforts.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. is trending as chatter focuses on Donald Trump's alleged connections to the Epstein case, with community members debating the validity and implications of related documents. Some are defending Trump, claiming the accusations are a hoax, while others criticize his associations and economic policies. The stock's performance and broader economic concerns under the current administration are also being discussed.

Memecoin on Injective taken over by the community.

Nonja

$NONJA.X is trending as the community rallies around its strong performance within the Injective ecosystem and its potential for high gains. Bullish sentiment is fueled by the anticipation of a staked $INJ ETF, which some believe could drive further momentum for this memecoin. Community members are actively discussing its unique features, such as the burned liquidity pool, and its potential to outperform other meme coins.

The TROLL token on the Solana network is a meme coin inspired by internet trolling culture, designed for entertainment and community engagement with no intrinsic value. Built on Solana’s blockchain, it leverages the network’s fast transactions and low fees to appeal to meme enthusiasts. Launched on decentralized exchanges, TROLL aims to foster a fun, community-driven ecosystem through social media, influencer partnerships, and viral marketing, embodying the playful spirit of online trolling.

Troll

TROLL.X is trending following news of the Solana memecoin officially acquiring rights to the Trollface meme, leading to a surge in market cap. The community is discussing its potential for significant gains, drawing comparisons to other successful meme coins and highlighting its strong community. Some users are also pointing to $GASH.X as another coin with similar potential.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAL is trending as the community discusses its potential in early cancer detection, highlighted by a recent article and a story about its life-saving importance. Some traders are taking profits, anticipating a retest, while others see long-term potential, particularly with possible FDA approval and broader access to its Galleri test. Volume and news catalysts are key talking points for future price movement.

Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner and Systems and Services segments. The Clear Aligner segment consists of invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Systems and Services segment includes sales related to iTero intraoral scanning systems, which includes a single hardware platform and restorative or orthodontic software options, upgrades and leases of scanner systems, sales of pre-owned scanner systems, subscription software, disposables, pay per scan services, as well as exocad’s CAD/CAM software solutions that integrate workflows to dental labs and dental practices. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Align Technology, Inc.

ALGN is trending as the community discusses recent price movement and future prospects, with some users drawing comparisons to SmileDirectClub's bankruptcy. Bullish investors point to share buybacks and insider buying as potential catalysts, while bears cite concerns about competition and market saturation. Discussions also include potential price targets and reactions to news from analysts.

WorldFinancial

World Liberty Financial (WLFI.X) is trending as the community discusses its potential role in revolutionizing finance, particularly through its USD1 stablecoin and tokenized real estate initiatives, with some highlighting potential conflicts involving Justin Sun. Community members are debating the token's long-term prospects, its ties to the Trump family, and its relationship with ALTS.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the U.S. Department of Commerce selected it to verify and distribute economic data onchain. The community is discussing its potential to disrupt the oracle space and integrate with DeFi protocols, drawing comparisons to Chainlink and CRO. Some users are speculating on price targets and anticipating the next leg up.

USELESS

$USELESS.X is gaining attention, with community members highlighting the potential for significant gains, referencing a possible 2000% move. Bullish sentiment seems to be driven by the coin's low market cap and community excitement around its potential, especially compared to other memecoins. Some users suggest that whales are accumulating $USELESS.X, anticipating a substantial pump.

Cyngn, Inc. engages in the development of autonomous driving software that can be deployed on multiple vehicle types in various environments. The company was founded by Kirt McMaster and Steve Kondik in 2013 and is headquartered in Mountain View, CA.

Cyngn Inc

CYN is trending due to a recent $300M mixed securities shelf offering, sparking concerns among investors about potential dilution and reverse stock splits. The community is actively discussing the implications of this offering, its effect on the stock's price, and the company's long-term financial stability. Despite a collaboration with NVIDIA, the stock's history of dilution and reverse splits remains a key point of discussion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Taysha Gene Therapies, Inc. (TSHA) Reports Q2 Loss, Beats Revenue Estimates

Taysha Gene Therapies (TSHA) delivered earnings and revenue surprises of -28.57% and +15.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates

Amphastar (AMPH) delivered earnings and revenue surprises of +19.72% and +2.69%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q2 Earnings? What You Should Know

Taysha Gene Therapies (TSHA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Taysha Gene Therapies (TSHA) Moves to Buy: Rationale Behind the Upgrade

Taysha Gene Therapies (TSHA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Personalis (PSNL) Surges 14.2%: Is This an Indication of Further Gains?

Personalis (PSNL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Retail buzz around Taysha Gene Therapies Inc surged Tuesday after the company released new clinical results from its TSHA-102 trial for Rett syndrome.Taysha Gene Therapies shares dipped 0.2% to close at $2.78 on Tuesday, before gaining 0.7% to $2.8 in after-hours trading.During its Reveal Phase 1/2 trials, the company presented recent cohort data for TSHA-102, which administered high and low doses to adolescent,&nbsp;adult, and pediatric patients&nbsp;through lumbar intrathecal delivery.Caregiver-reported improvements in developmental milestones supported Taysha’s alignment with the U.S. Food and Drug Administration (FDA) on the primary endpoint for the pivotal Part B trial of TSHA-102.Previously released preclinical data demonstrated broad biodistribution of AAV9 gene therapy vectors across brain and spinal cord regions in non-human primates.Taysha will present these findings in three oral presentations and a poster session at the 2025 International Rett Syndrome Foundation (IRSF) Scientific Meeting in Boston, June 9-11.Canaccord Genuity raised its price target on Taysha shares to $11 from $9, while maintaining a ‘Buy’ rating, citing positive longer-term low-dose follow-up and initial high-dose data disclosed by the company.&nbsp;The research firm also increased its assigned probability of success (POS) for TSHA-102 to 75% from 50%.Canaccord’s updated model also factored in the recently announced approximately $200 million offering via a combination of shares and prefunded warrants.On Stocktwits, retail sentiment was ‘extremely bullish’ amid ‘high’ message volume.One user noted that it is unusual for a stock to increase during an offering, welcoming Taysha as an exception.&nbsp;<stembedurl>https://stocktwits.com/KING_OF_BIO/message/616691905</stembedurl>Another user highlighted that all price targets for Taysha have been raised.<stembedurl>https://stocktwits.com/strategicmind/message/616553737</stembedurl>The stock has risen 50.3% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Retail Buzz Surges Around Taysha Gene Therapies After Positive Rett Syndrome Trial Data

Canaccord Genuity raised its price target on Taysha Gene Therapies to $11 from $9, citing improved clinical data and increased confidence in the company’s TSHA-102 program. 

Equity

Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Tops Revenue Estimates

Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Trump Rally Fizzles: Futures Drop As Dollar, Yields Extend Surge

Trump Rally Fizzles: Futures Drop As Dollar, Yields Extend Surge

 The torrid five-day rally that pushed the S&P 500 to its 51st record close above 6,000 on Monday has finally reversed...

Analysts Are Bullish on Top Healthcare Stocks: Beam Therapeutics (BEAM), Taysha Gene Therapies (TSHA)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Beam Therapeutics (BEAM Research Report) and Taysha Gene Therapies...

Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing. The company was founded by Steven Gray, Berge Minassian, and R. A. Session II in 2019 and is headquartered in Dallas, TX.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.09	--	--	N/A
Q2 '25	-$0.08	-$0.09	-15.57%	MISSED
Q1 '25	-$0.09	-$0.08	8.68%	BEAT
Q4 '24	-$0.08	-$0.07	13.91%	BEAT
Q3 '24	-$0.09	-$0.10	-15.31%	MISSED

TSHA
Taysha Gene Therapies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '25

Historical Earnings

Latest TSHA News

TSHA Taysha Gene Therapies Inc